All Posts Tagged With: "ANDS"
(ANDS) Anadys Pharmaceuticals Announces Good News For Hepatitis Candidate
Anadys Pharmaceuticals Inc. (ANDS) announced that its lead candidate, ANA598, which is being developed for treating patients with hepatitis C virus (HCV) infections, has met key goals in a mid-stage study.
The...
(ANDS) Anadys Pharmaceuticals Reports Positive Study Data
Anadys Pharmaceuticals Inc. (ANDS) announced that its lead candidate, ANA598, which is being developed for treating patients with hepatitis C virus (HCV) infections, has met its key goals in a mid-stage study.
The...
(ANDS) Anadys Pharmaceuticals Drug Meets Key Study Goals
Anadys Pharmaceuticals Inc. (ANDS) announced that its lead candidate, ANA598, which is being developed for treating patients with hepatitis C virus (HCV) infections has met its key goals in a mid-stage study.
The...
(ANDS) Anadys Begins Mid-Stage Trial
Yesterday, Anadys Pharmaceuticals Inc. (ANDS) started a 12-week phase II trial of its ANA598 for hepatitis C patients. ANA 598 will be evaluated in combination with interferon-alpha and ribavirin (current standard of care) in the mid-stage study. Data from...